Caracas, Venezuela – October 2024 – Megalabs Venezuela has announced the appointment of Alberto Wallis as Chief Financial Officer. Wallis will be responsible for leading the financial strategy and operations of the company, aiming to enhance financial performance, support strategic growth, and ensure sustainable development in the healthcare sector across Venezuela.
Prior to his appointment as CFO, Wallis served as New Business Manager at Megalabs Venezuela, where he contributed to the company’s business development efforts, identifying new growth opportunities and implementing financial strategies to support expansion. His expertise in finance and market analysis played a critical role in driving the company’s initiatives over the past 10 months.
Before joining Megalabs, Wallis worked as a Research Associate at Tegus, where he conducted in-depth market research and financial analysis, delivering insights to support investment decisions. Earlier in his career, he was a Financial Analyst at Fincredible AI, where he focused on financial modeling and content development. His background also includes roles as a Senior Analyst at Magna Capital and a Contributor at Seeking Alpha, where he provided equity research and valuation insights.
Wallis’s early professional experiences include an Analytics & Insights Internship at Procter & Gamble and a Research Analyst role at B612 Capital, where he gained valuable skills in financial analysis and research writing.
About Megalabs Venezuela
Megalabs Venezuela is a leading branded pharmaceutical company dedicated to affordable therapeutic solutions and innovation in healthcare. Committed to the sustainable development and well-being of the Venezuelan population, Megalabs holds a strong position in 20 Latin American markets, providing essential medical care and maintaining a focus on quality and life awareness.
Read Also : Cultivating Safe Spaces: The Strategic Role of L&D in Workplace Well-being
